semaglutide and kidney failure Research shows — commonly sold as Ozempic or Wegovy — can improve function survival Semaglutides Are Poised to Remake

Psychosomatic Medicine 73 :344-349

Clinical evidences on the DPP-4 inhibitor sitagliptin suggests it is associated with a decreased risk of prostate cancer [106, 110], and long-term administration of this agent may have potential benefits for breast cancer [96]

Independent studies have confirmed the consistency and quality of the active ingredients, reinforcing our confidence in their effectiveness

The benefit holds across populations: in women of reproductive age , six months of 600 mg myo-inositol and 83 mcg selenium improved TSH, autoimmunity markers and ultrasound, and eased symptoms such as fatigue, weight changes and cold intolerance (Payer et al., 2022), with possible prevention of subclinical hypothyroidism in pregnancy (Porcaro and Angelozzi, 2018)